drugset / Trial / NCT02488980
An Evaluation of Weekly Tafenoquine
Phase 2
Completed
306 enrolled
U.S. Army Medical Research and Development Command
SmithKline Beecham · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This was a placebo controlled, randomised, double-blind, double-dummy study of the efficacy of weekly tafenoquine compared with weekly mefloquine or placebo in the chemosuppression of P. falciparum in Nyanza Province, western Kenya.
Timeline
- Start
- 2000-05
- Primary completion
- 2000-10
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mefloquine | Unknown | 250 mg | — |
| Subject | Tafenoquine | Small molecule | 200 mg | — |